Entheon Announces Change of Directors
Rhea-AI Summary
Entheon Biomedical Corp (CSE: ENBI) (OTCQB: ENTBF) has announced a change in its Board of Directors. Harrison Newlands has been appointed to the board effective April 3, 2025, while Andrew Hegle has resigned.
Newlands brings nearly a decade of experience in start-ups and capital markets. His notable achievements include co-founding Fire & Flower, a Canadian retail cannabis company, where he served as Director of Business Development. He also co-founded Hoshi International, a medicinal cannabis producer in Portugal, and Hypercharge Networks, Canada's first publicly traded EV charging company.
His career began as a Research Associate at MacNicol and Associates on Bay Street. He has also served as a strategic advisor for Taiga Motors, was formerly a partner at Rockbank Capital, and currently serves as a managing partner at North King Capital, where he advises public and private companies.
Positive
- Appointment of experienced director with extensive cannabis industry expertise
- New director brings strong background in capital markets and start-up development
- Addition of director with successful track record in founding and scaling companies
Negative
- Loss of existing board member Andrew Hegle
News Market Reaction – ENTBF
On the day this news was published, ENTBF declined 8.66%, reflecting a notable negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Vancouver, British Columbia--(Newsfile Corp. - April 4, 2025) - Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU) ("Entheon" or the "Company") announces the appointment of Harrison Newlands to the Company's Board of Directors, effective April 3, 2025.
Harrison Newlands has a diverse understanding of start-ups and capital markets, having invested, advised, and helped co-found dozens of mid-cap companies spanning close to a decade of experience in the industry. He started his career working on Bay Street as a Research Associate at MacNicol and Associates, thereafter he jumped into the fast growing cannabis industry, and was one of the co-founders of Fire & Flower, one of Canada's first retail focused cannabis companies, where he led its early growth and served as Director of Business Development. Shortly thereafter, he helped take the first EV company public in Canada, Taiga Motors, where he served as a strategic advisor.
Mr. Newlands also co-founded Hoshi International, a producer of medicinal cannabis with a state of the art facility in Portugal, focusing on the emerging European market. Harrison also co-founded Hypercharge Networks, Canada's first publicly traded EV charging company. Harrison was formerly a partner at Rockbank Capital, a Vancouver based merchant bank, and has been a managing partner at North King Capital over the past 4 years, where he continues to advise both public and private companies, as well as invest.
Andrew Hegle has resigned from the Company's Board of Directors. The Company wishes to thank Mr. Hegle for his services and wishes him all the best in future endeavours.
About Entheon Biomedical Corp.
Entheon is a biotechnology research and development company interested in treating addiction and substance use disorders.
On Behalf of the Board of Directors,
Timothy Ko, CEO, President and Director
For more information, please contact the Company at:
Entheon Biomedical Corp.
Timothy Ko, CEO
1 (604) 562-3932
timothy@entheonbiomedical.com
https://entheonbiomedical.com
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/247466
FAQ
When did Harrison Newlands join Entheon Biomedical's (ENTBF) Board of Directors?
What is Harrison Newlands' experience in the cannabis industry for ENTBF?
Which board member resigned from Entheon Biomedical (ENTBF)?
What are Harrison Newlands' current business activities related to ENTBF?
